Endothelium function in sepsis

Inflammation Research

Volumn 49, Issue 5, 2000, Pages 185-198

  Volk, T ^a   Kox, W J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Coagulation; Endothelium; Gulation; Permeability; Sepsis; Vasore

Indexed keywords

ALPHA TOXIN; BACTERIAL TOXIN; CYSTEINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EXOTOXIN; FIBRINOGEN; HEMOLYSIN; HEPARAN SULFATE; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; LISTERIOLYSIN; NITRIC OXIDE; OUTER MEMBRANE PROTEIN; PADGEM PROTEIN; PHOSPHOLIPASE C; POLYSACCHARIDE; PROTEINASE; REACTIVE OXYGEN METABOLITE; STREPTOLYSIN S; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TOXIN; VASCULAR CELL ADHESION MOLECULE 1; VEROTOXIN;

BLOOD CLOTTING; BLOOD VESSEL REACTIVITY; CELL ACTIVATION; CELL INTERACTION; ENDOTHELIUM; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; NONHUMAN; PATHOGENESIS; PERMEABILITY; REVIEW; SEPSIS;

ANIMALS; BACTERIAL INFECTIONS; ENDOTHELIUM; HUMANS; SEPSIS;

EID: 0034123126     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050579     Document Type: Review

References (199)

1. [1] Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients wit bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42: 1762-70.
2. [2] Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
3. [3] Menzies BE, Kourteva I. Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect Immun 1998; 66: 5994-8.
4. [4] Vesga O, Groeschel MC, Otten MF, Brar DW, Vann JM, Proctor RA. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu, J Infect Dis 1996; 173: 739-42.
5. [5] Burns EH, Lukomski S, Rurangirwa J, Podbielski A, Musser JM. Genetic inactivation of the extracellular cysteine protease enhances in vitro internalization of group A streptococci by human epithelial and endothelial cells. Microb Pathog 1998; 24: 333-9.
6. [6] Ginsburg I, Varani J. Interaction of viable group A streptococci and hydrogen peroxide in killing of vascular endothelial cells. Free Radic Biol Med 1993; 14: 495-500.
7. [7] Gibson RL, Lee MK, Soderland C, Chi EY, Rubens CE. Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion. Infect Immun 1993; 61: 478-85.
8. [8] Nizet V, Kim KS, Stins M, Jonas M, Chi EY, Nguyen D, et al. Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun 1997; 65: 5074-81.
9. [9] Cundell DR, Gerard NP, Gerard C, Idanpaan HI, Tuomanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995; 377: 435-8.
10. [10] Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest 1998; 102: 347-60.
11. [11] Schwarzer N, Nost R, Seybold J, Parida SK, Fuhrmann O, Krull M, et al. Two distinct phospholipases C of Listeria monocytogenes induce ceramide generation, nuclear factor-kappa acivation, and E-selectin expression in human endothelial cells. J Immunol 1998; 161: 3010-8.
12. [12] Parida SK, Domann E, Rohde M, Muller S, Darji A, Hain T, et al. Internalin B is essential for adhesion and mediates the invasion of Listeria monocytogenes into human endothelial cells. Mol Microbiol 1998; 28: 81-93.
13. [13] Noel-RF J, Sato TT, Mendez C, Johnson MC, Pohlman TH. Activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble CD14. Infect Immun 1995; 63: 4046-53.
14. [14] Pron B, Taha MK, Rambaud C, Forunet JC, Pattey N, Monnet JP, et al. Interaction of Neisseria maningitidis with the components of the blood-brain barrier correlates with an increased expression of PilC. J Infect Dis 1997; 176: 1285-92.
15. [15] Virji M, Watt SM, Barker S, Makepeace K, Doyonnas R. The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol Microbiol 1996; 22: 929-39.
16. [16] Quinn FD, Weyant RS, Worley MJ, White EH, Utt FA, Ades EA. Human microvascular endothelial tissue culture cell model for studying pathogenesis of Brazilian purpuric fever. Infect Immun 1995; 63: 2317-22.
17. [17] Plotkowski MC, Saliba AM, Pereira SH, Cervante MP, Bajolet LO. Pseudomonas aeruginosa selective adherence to and entry into human endothelial cells. Infect Immun 1994; 62: 5456-63.
18. [18] Plotkowski MC, Meirelles MN. Cincomitant endosome-phagosome fusion and lysis of endosomal membranes account for Pseudomonas aeruginosa survival in human endothelial cells. J Submicrosc Cytol Pathol 1997; 29: 229-37.
19. [19] Prasadarao NV, Wass CA, Kim KS. Endothelial cell GlcNAc beta 1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrier. Infect Immun 1996; 64: 154-60.
20. [20] Huang SH, Wass C, Fu Q, Prasadarao NV, Stins M, Kim KS. Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10. Infect Immun 1995; 63: 4470-5.
21. [21] Molestina RE, Dean D, Miller RD, Ramirez JA, Summersgill JT. Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect Immun 1998; 66: 1370-6.
22. [22] Fryer RH, Schwobe EP, Woods ML, Rodgers GM. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Investig Med 1997; 45: 168-74.
23. [23] Krull M, Klucken AC, Wuppermann FN, Fuhrmann O, Magerl C, Seybold J, et al. Signal Transduction Pathways Activated in Endothelial Cells Following Infection with Chlamydia pneumoniae. J Immunol 1999; 162: 4834-41.
24. [24] Drancourt M, Mainardi JL, Brouqui P, Vandenesch F, Carta A, Lehnert F, et al. Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med 1995; 332: 419-23.
25. [25] Brouqui P, Raoult D. Bartonella quintana invades and multiplies within endothelial cells in vitro and in vivo and forms intracellular blebs. Res Microbiol 1996; 147: 719-31.
26. [26] Dehio C, Meyer M, Berger J, Schwarz H, Lanz C. Interaction of Bartonella henselae with endothelial cells results in bacterial aggregation on the cell surface and the subsequent engulfment and internalisation of the bacterial aggregate by a unique structure, the invasome. J Cell Sci 1997; 110: 2141-54.
27. [27] Clifton DR, Goss RA, Sahni SK, van-Antwerp D, Baggs RE, Marder VJ, et al. NF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection. Proc Natl Acad Sci USA 1998; 95: 4646-51.
28. [28] Dignat GF, Teysseire N, Mutin M, Bardin N, Lesaule G, Raoult D, et al. Rickettsia conorii infection enhances vascular cell adhesion molecule-1- and intercellular adhesion molecule-1-dependent mononuclear cell adherence to endothelial cells. J Infect Dis 1997; 175: 1142-52.
29. [29] Kaplanski G, Teysseire N, Farnarier C, Kaplanski S, Lissitzky JC, Durand JM, et al. IL-6 and IL-8 production from cultured human endothelial cells stimulated by infect on with Rickettsia conorii via a cell-associated IL-1 alpha-dependent pathway. J Clin Invest 1995; 96: 2839-44.
30. [30] Wooten RM, Morrison TB, Weis JH, Wright SD, Thieringer R, Weis JJ. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol 1998; 160: 5485-92.
31. [31] Coburn J, Magoun L, Bodary SC, Leong JM. Integrins alpha(v)beta3 and alpha5beta1 mediate attachment of lyme disease spirochetes to human cells. Infect Immun 1998; 66: 1946-52.
32. [32] Leong JM, Wang H, Magoun L, Field JA, Morrissey PE, Robbins D, et al. Different classes of proteoglycans contribute to the attachment of Borrelia burgdorferi to cultured endothelial and brain cells. Infect Immun 1998; 66: 994-9.
33. [33] Boggemeyer E, Stehle T, Schaible UF, Hahne M, Vestweber D, Simon MM. Borrelia burgdorferi upregulates the adhesion molecules E-selectin, P-selectin, ICAM-1 and VCAM-1 on mouse endothelioma cells in vitro. Cell Adhes Commun 1994; 2: 145-57.
34. [34] Ho M, Schollaardt T, Niu X, Looareesuwan S, Patel KD, Kubes P. Characterization of Plasmodium falciparum-infected erythrocyte and P-selectin interaction under flow conditions. Blood 1998; 91: 4803-9.
35. [35] McCormick CJ, Craig A, Roberts D, .Newbold CI, Berendt AR. Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells. J Clin Invest 1997; 100: 2521-9.
36. [36] Treutiger CJ, Heddini A, Fernandez V, Muller WA, Wahlgren M. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nat Med 1997; 3: 1405-8.
37. [37] Filler SG, Pfunder AS, Spellberg BJ, Spellberg JP, Edwards-JE J. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells, Infect Immun 1996; 64: 2609-17.
38. [38] Ibrahim AS, Filler SG, Sanglard D, Edwards-JE J, Hube B. Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells. Infect Immun 1998; 66: 3003-5.
39. [39] Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M, Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998; 161: 6338-46.
40. [40] Brankin B, Hart MN, Cosby SL, Fabry Z, Allen IV. Adhesion molecule expression and lymphocyte adhesion to cerebral endothelium: effects of measles virus and herpes simplex 1 virus. J Neuroimmunol 1995; 56: 1-8.
41. [41] Mazure G, Grundy JE, Nygard G, Hudson M, Khan K, Srai K, et al. Measles virus induction of human endothelial cell tissue factor procoagulant activity in vitro. J Gen Virol 1994; 75: 2863-71.
42. [42] Vercellotti GM. Effects of viral activation of the vessel wall on inflammation and thrombosis. Blood Coagul Fibrinolysis 1998; 9 Suppl 2: S3-S6.
43. [43] Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 1999; 73: 3951-9.
44. [44] Harcourt BH, Sanchez A, Offermann MK. Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells. Virology 1998; 252: 179-88.
45. [45] Grimminger F, Rose F, Sibelius U, Meinhardt M, Potzsch B, Spriestersbach R, et al. Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. J Immunol 1997; 159: 1909-16.
46. [46] Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989; 2: 15-38.
47. [47] Bunting M, Lorant DE, Bryant AE, Zimmermann GA, McIntyre TM, Stevens DL, et al. Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest 1997; 100: 565-74.
48. [48] Chen Z, Zandonatti M, Jakubowski D, Fox HS. Brain capillary endothelial cells express MBEC1, a protein that is related to the Clostridium perfringens enterotoxin receptors. Lab Invest 1998; 78: 353-63.
49. [49] Bryant AE, Stevens DL. Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect Immun 1996; 64: 358-62.
50. [50] Hippenstiel S, Tannert OS, Vollrath N, Krull M, Just I, Aktories K, et al. Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function. Am J Physiol 1997; 272: L38-L43.
51. [51] Essler M, Hermann K, Amano M, Kaibuchi K, Heeseman J, Weber PC, et al. Pasteurella multocida toxin increases endothelial permeability via Rho kinase and myosin light chain phosphatase. J Immunol 1998; 161: 5640-6.
52. [52] Baluna R, Rizo J, Gordon BE, Ghetie V, Vitetta ES. Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome. Proc Natl Acad Sci USA 1999; 96; 3957-62.
53. [53] Sibelius U, Chakraborty T, Krogel B, Wolf J, Rose F, Schmidt R, et al. The listerial exotoxins listeriolysin and phosphatidylinositol-specific phospholipase C synergize to elicit endothelial cell phosphoinositide metabolism. J Immunol 1996; 157: 4055-60.
54. [54] Kawamura N, Imanishi N, Koike H, Nakahara H, Phillips L, Morooka S. Lipoteichoic acid-induced neutrophil adhesion via E-selectin to human umbilical vein endothelial cells (HUVECs). Biochem Biophys Res Commun 1995; 217: 1208-15.
55. [55] Jin Y, Gupta D, Dziarski R. Endothelial and epithelial cells do not respond to complexes of peptidoglycan with soluble CD14 but are activated indirectly by peptidoglycan-induced tumor necrosis factor-alpha and interleukin-1 from monocytes. J Infect Dis 1998; 177: 1629-38.
56. [56] Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-51.
57. [57] Mantovani A, Bussolino F, Introna M. Cytokine regulation of endothelial cell function: from molecular level to he bedside. Immunol Today 1997; 18: 231-40.
58. [58] Britigan BE, Rasmussen GT, Cox CD. Pseudomonas siderophore pyochelin enhances neutrophil-mediated endothelial cell injury. Am J Physiol 1994; 266: L192-L198.
59. [59] Hong JE, Santucci LA, Tian X, Silverman DJ. Superoxide dismutase-dependent, catalase-sensitive peroxides in human endothelial cells infected by Rickettsia rickettsii. Infect Immun 1998; 66: 1293-8.
60. [60] Privat C, Stepien O, David-Dufilho M, Brunei A, Bedioui F, Marche P, et al. Superoxide release from interleukin-1B-stimulated human vascular cells: in situ electrochemical measuremeut. Free Radic Biol Med 1999; 27: 554-9.
61. [61] Maziere C, Conte MA, Dantin F, Maziere JC. Lipopolysaccharide enhances oxidative modification of low density lipoprotein by copper ions, endothelial and smooth muscle cells. Atherosclerosis 1999; 143: 75-80.
62. [62] Rahman A, Kefer J, Bando M, Niles WD, Malik AB. E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation. Am J Physiol 1998; 275: L533-L544.
63. [63] Murphy HS, Shayman JA, Till GO, Mahrougui M, Owens CB, Ryan US, et al. Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways. Am J Physiol 1992; 263: L51-9.
64. [64] Bhunia AK, Arai T, Bulkley G, Chatterjee S. Lactosylceramide mediates tumor necrosis factor-alpha induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells. J Biol Chem 1998; 273: 34349-57.
65. [65] Mitchell J, Jiang H, Berry L, Meyrick B. Effect of antioxidants on lipopolysaccharide-stimulated induction of mangano superoxide dismutase mRNA in bovine pulmonary artery endothelial cells. J Cell Physiol 1996; 169: 333-40.
66. [66] Arai T, Kelly SA, Brengman ML, Takano M, Smith EH, Goldschmidt CP, et al. Ambient but not incremental oxidant generation effects intercellular adhesion molecule 1 induction by tumour necrosis factor alpha in endothelium. Biochem J 1998; 331: 853-61.
67. [67] d'Alessio P, Moutet M, Coudrier E, Darquenne S, Chaudiere J. ICAM-1 and VCAM-1 expression induced by TNF-alpha are inhibited by a glutathione peroxidase mimic. Free Radic Biol Med 1998; 24: 979-87.
68. [68] Moutet M, d'Alessio P, Malette P, Devaux V, Chaudiere J. Glutathione peroxidase mimics prevent TNFalpha- and neutrophil-induced endothelial alterations. Free Radic Biol Med 1998; 25: 270-81.
69. [69] Suttorp N, Fuhrmann M, Tannert OS, Grimminger F, Bhadki S. Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells. J Exp Med 1993; 178: 337-41.
70. [70] Walker DH, Popov VL, Crocquet VP, Welsh CJ, Feng HM. Cytokine-induced, nitric oxide-dependent, intracellular antirickettsial activity of mouse endothelial cells. Lab Invest 1997; 76: 129-38.
71. [71] Oswald IP, Eltoum I, Wynn TA, Schwartz B, Caspar P, Paulin D, et al. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Proc Natl Acad Sci USA 1994; 91: 999-1003.
72. [72] Graier WF, Myers PR, Rubin LJ, Adams HR, Parker JL. Escherichia coli endotoxin inhibits agonistmediated cytosolic Ca2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells. Circ Res 1994; 75: 659-68.
73. [73] Forstermann U, Boissel JP, Kleinert H. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998; 12: 773-90.
74. [74] Peng HB, Spiecker M, Liao JK. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol 1998; 161: 1970-6.
75. [75] Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4
76. [76] Chang J, Rao NV, Markewitz BA, Hoidal JR, Michael JR. Nitric oxide donor prevents hydrogen peroxide-mediated endothelial cell injury. Am J Physiol 1996; 270: L931-40.
77. [77] Gupta MP, Evanoff V, Hart CM. Nitric oxide attenuates hydrogen peroxide-mediated injury to porcine pulmonary artery endothelial cells. Am J Physiol 1997; 272: L1133-L1141.
78. [78] Shimizu S, Ishii M, Kawakami Y, Momose K, Yamamoto T. Protective effects of tetrahydrobiopterin against nitric oxide-induced endothelial cell death. Life Sci 1998; 63: 1585-92.
79. [79] Volk T, Ioannidis I, Hensel M, deGroot H, Kox WJ. Endothelial damage induced by nitric oxide: synergism with reactive oxygen species. Biochem Biophys Res Commun 1995; 213: 196-203.
80. [80] Nappi AJ, Vass E. Hydroxyl radical formation resulting from the interaction of nitric oxide and hydrogen peroxide. Biochim Biophys Acta 1998; 1380: 55-63.
81. [81] Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B van d V. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391: 393-7.
82. [82] Ceneviva GD, Tzeng E, Hoyt DG, Yee E, Gallagher A, Engelhardt JF, et al. Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells. Am J Physiol 1998; 275: L717-L728.
83. [83] Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 1997; 186: 1831-41.
84. [84] Hu X, Yee E, Harlan JM, Wong F, Karsan A. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood 1998; 92: 2759-65.
85. [85] Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Buchman TG, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27: 1230-51.
86. [86] Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-71.
87. [87] Barchowsky A, Munro SR, Morana SJ, Vincenti MP, Treadwell M. Oxidant-sensitive and phosphorylation-dependent activation of NF-kappa B and AP-1 in endothelial cells. Am J Physiol 1995; 269: L829-L836.
88. [88] Bradley JR, Johnson DR, Pober JS. Endothelial activation by hydrogen peroxide. Selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. Am J Pathol 1993; 142:L 1598-609.
89. [89] Soares MP, Muniappan A, Kaczmarek E, Koziak K, Wrighton CJ, Steinhauslin F, et al. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitzing to apoptosis. J Immunol 1998; 161: 4572-82.
90. [90] Bohrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Mannel D, et al. Role of NFkappaB in the mortality of sepsis. J Clin Invest 1997; 100: 972-85.
91. [91] Ziegelstein RC, Corda S, Pili R, Passaniti A, Lefer D, Zweier JL, et al. Initial contact and subsequent adhesion of human neutrophils or monocytes to human aortic endothelial cells releases an endothelial intracellular calcium store. Circulation 1994; 90: 1899-907.
92. [92] Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-8.
93. [93] Jollow KC, Zimring JC, Sundstrom JB, Ansari AA. CD40 ligation induced phenotypic and functional expression of CD80 by human cardiac microvascular endothelial cells. Transplantation 1999; 68: 430-9.
94. [94] Tietz W, Allemand Y, Borges E, von-Laer D, Hallmann R, Vestweber D, et al. CD4+ T cells migrate into inflamed skin only if they express ligands for E- and P-selectin. J Immunol 1998; 161: 963-70.
95. [95] Ferguson NR, Galley HF, Webster NR. T helper cell subset ratios in patients with severe sepsis. Intensive Care Med 1999; 25: 106-9.
96. [96] Ozaki H, Ishii K, Horiuchi H, Arai H, Kawamoto T, Okawa K, et al. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol 1999; 163: 553-7.
97. [97] Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol 1999; 163: 682-8.
98. [98] Noble KE, Wickremasinghe RG, DeCornet C, Panayiotidis P, Yong KL. Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. J Immunol 1999; 162; 1376-83.
99. [99] Walsh K, Sata M. Negative Regulation of Inflammation by Fas Ligand Expression on the Vascular Endothelium. Trends Cardiovasc Med 1999; 9: 34-41.
100. [100] Gipson TS, Bless NM, Shanley TP, Crouch LD, Bleavins MR, Younkin EM, et al. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J Immunol 1999; 162: 3653-62.
101. [101] Lennon PF, Taylor CT, Stahl GL, Colgan SP. Neutrophil-derived 5′-adenosine monophosphat promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med 1998; 188: 1433-43.
102. [102] Wagner JG, Roth RA. Neutrophil migration during endotoxemia. J Leukoc Biol 1999; 66: 10-24.
103. [103] Draijer R, Vaandrager AB, Nolte C, de-Jonge HR, Walter U van HV. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res 1995; 77: 897-905.
104. [104] Moore TM, Chetham PM, Kelly JJ, Stevens T. Signal transduction and regulation of lung endothelial cell permeability interaction between calcium and cAMP. Am J Physiol 1998; 275: L203-L222.
105. [105] Suttorp N, Hessz T, Seeger W, Wilke A, Koob R, Lutz F, et al. Bacterial exotoxins and endothelial permeability for water and albumin in vitro. Am J Physiol 1988; 255: C368-C376.
106. [106] Suttorp N, Floer B, Schnittler H, Seeger W, Bhakdi S. Effects of Escherichia coli hemolysin on endothelial cell function. Infect Immun 1990; 58: 3796-801.
107. [107] Bannerman DD, Fitzpatrick MJ, Anderson DY, Bhattacharjee AK, Novitsky TJ, Hasday JD, et al. Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction. Infect Immun 1998; 66: 1400-7.
108. [108] Bannerman DD, Sathyamoorthy M, Goldblum SE. Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins. J Biol Chem 1998; 273: 35371-80.
109. [109] Dimmeler S, Brinkmann S, Neugebauer E. Endotoxin-induced changes of endothelial cell viability and permeability: protective effect of a 21-aminosteroid. Eur J Pharmacol 1995; 287: 257-61.
110. [110] Allport JR, Ding H, Collins T, Gerritsen ME, Luscinskas FW. Endothelial-dependent mechanisms regulate leukocyte transmigration: a process involving the proteasome and disruption of the vascular endothelial-cadherin complex at endothelial cell-to-cell junctions. J Exp Med 1997; 186: 517-27.
111. [111] Koga S, Morris S, Ogawa S, Liao H, Bilezikian JP, Chen G, et al. TNF modulates endothelial properties by decreasing cAMP. Am J Physiol 1995; 268: C1104-C1113.
112. [112] Suttorp N, Hippenstiel S, Fuhrmann M, Krull M, Podzuweit T. Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability. Am J Physiol 1996; 270: C778-85.
113. [113] Topper JN, Wasserman SM, Anderson KR, Cai J, Falb D, Gimbrone-MA J. Expression of the bumetanide-sensitive Na-K-Cl cotransporter BSC2 is differentially regulated by fluid mechanical and inflammatory cytokine stimuli in vascular endothelium. J Clin Invest 1997; 99: 2941-9.
114. [114] Deng X, Wang X, Andersson R. Endothelial barrier resistance in multiple organs after septic and nonseptic challenges in the rat. J Appl Physiol 1995; 78: 2052-61.
115. [115] Schmidt H, Schmidt W, Muller T, Bohrer H, Gebhard MM, Martin E. N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Crit Care Med 1997; 25: 858-63.
116. [116] Schmidt H, Schmidt W, Muller T, Bohrer H, Bach A, Gebhard MM, et al. Effect of the 21-aminosteroid tirilazad mesylate on leukocyte adhesion and macromolecular leakage during endotoxemia. Surgery 1997; 121: 328-34.
117. [117] Hickey MJ, Issekutz AC, Reinhardt PH, Fedorak RN, Kubes P. Endogenous interleukin-10 regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia. Circ Res 1998; 83: 1124-31.
118. [118] Christ F, Gamble J, Gartside IB, Kox WJ. Increased microvascular water permeability in patients with septic shock, assessed with venous congestion plethysmography (VCP). Intensive Care Med 1998; 24: 18-27.
119. [119] Irokawa M, Nishinaga M, Ikeda U, Shinoda Y, Suematsu M, Gouda N, et al. Endothelial-derived nitric oxide preserves anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. Atherosclerosis 1997; 135: 9-17.
120. [120] Wang W, Diamond SL. Does elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells? Biochem Biophys Res Commun 1997; 233: 748-51.
121. [121] Papapetropoulos A, Piccardoni P, Cirino G, Bucci M, Sorrentino R, Cicala C, et al. Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. Proc Natl Acad Sci USA 1998; 95: 4738-42.
122. [122] Hirokawa K, Aoki N. Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro. J Biochem Tokyo 1990; 108: 839-45.
123. [123] Calnek DS, Grinnell BW. Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor. Exp Cell Res 1998; 238: 294-8.
124. [124] Bodin P, Birnstock G. Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res 1999; 47; 351-4.
125. [125] Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, et al. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 1997; 185: 153-63.
126. [126] Matsumoto Y, Kawai Y, Watanabe K, Sakai K, Murata M, Handa M, et al. Fluid shear stress attenuates tumor necrosis factor-alpha-induced tissue factor expression in cultured human endothelial cells. Blood 1998; 91: 4164-72.
127. [127] Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
128. [128] Osterud B, Bajaj MS, Bajaj SP. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 73: 873-5.
129. [129] Matsumoto H, Ueshima S, Fukao H, Mitsui Y, Matsuo O. Effects of lipopolysaccharide on the expression of fibrinolytic factors in an established cell line from human endothelial cells. Life Sci 1996; 59: 85-96.
130. [130] Okada H, Woodcock MJ, Mitchell J, Sakamoto T, Marutsuka K, Sobel BE, et al. Induction of plasminogen activator inhibitor type 1 and type 1 collagen expression in rat cardiac microvascular endothelial cells by interleukin-1 and its dependence on oxygen-centered free radicals. Circulation 1998; 97: 2175-82.
131. [131] Duboscq C, Quintana I, Bassilotta E, Bergonzelli GE, Porterie P, Sassetti B, et al. Plasminogen: an important hemostatic parameter in septic patients. Thromb Haemost 1997; 77: 1090-5.
132. [132] Johnson K, Choi Y, DeGroot E, Samuels I, Creasey A, Aarden L. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998; 160: 5130-5.
133. [133] Kaplanski G, Marin V, Fabrigoule M, Boulay V, Benoliel AM, Bongrand P, et al. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 1998; 92: 1259-67.
134. [134] Roy SS, Saifeddine M, Loutzenhiser R, Triggle CR, Hollenberg MD. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Br J Pharmacol 1998; 123: 1434-40.
135. [135] Herwald H, Morgelin M, Olsen A, Rhen M, Dahlback B, Muller Esterl W, et al. Activation of the contact-phase system on bacterial surfaces - a clue to serious complications in infectious diseases. Nat Med 1998; 4: 298-302.
136. [136] Altura BM, Gebrewold A, Burton RW. Reactive hyperemic responses of single arterioles are attenuated markedly after intestinal ischemia, endotoxemia and traumatic shock: possible role of endothelial cells. Microcirc Endothelium Lymphatics 1985; 2: 3-14.
137. [137] Altura BM, Gebrewold A, Burton RW. Failure of microscopic metarterioles to elicit vasodilator responses to acetylcholine, bradykinin, histamine and substance P after ischemic shock, endotoxemia and trauma: possible role of endothelial cells. Microcirc Endothelium Lymphatics 1985; 2: 121-7.
138. [138] McKenna TM, Martin FM, Chernow B, Briglia FA. Vascular endothelium contributes to decreased aortic contractility in experimental sepsis. Circ Shock 1986; 19: 267-73.
139. [139] Parker JL, Adams HR. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res 1993; 72: 539-51.
140. [140] Myers PR, Zhong Q, Jones JJ, Tanner MA, Adams HR, Parker JL. Release of EDRF and NO in ex vivo perfused aorta: inhibition by in vivo E. coli endotoxemia. Am J Physiol 1995; 268: H955-H961.
141. [141] Parker JL, Myers PR, Zhong Q, Kim K, Adams HR. Inhibition of endothelium-dependent vasodilation by Escherichia coli endotoxemia. Shock 1994; 2: 451-8.
142. [142] Myers PR, Gupta M, Rogers S, Mattox ML, Adams HR, Parker JL. Chronic endotoxemia and endothelium-dependent vasodilation in coronary arteries. Shock 1996; 6: 267-73.
143. [143] Wang SY, Cameron EM, Fink MP, Sellke FW. Chronic septicemia alters alpha-adrenergic mechanisms in the coronary circulation. J Surg Res 1997; 69: 61-6.
144. [144] Cameron EM, Wang SY, Fink MP, Sellke FW. Mesenteric and skeletal muscle microvascular responsiveness in subacute sepsis. Shock 1998; 9: 184-92.
145. [145] Curzen NP, Griffiths MJ, Evans TW. Contraction to endothelin-1 in pulmonary arteries from endotoxin-treated rats is modulated by endothelium. Am J Physiol 1995; 268: H2260-H2266.
146. [146] Kadletz M, Dignan RJ, Mullen PG, Windsor AC, Sugerman HJ, Wechsler AS. Pulmonary artery endothelial cell function in swine pseudomonas sepsis. J Surg Res 1996; 60: 186-92.
147. [147] Wang P, Ba ZF, Chaudry IH. Nitric oxide. To block or enhance its production during sepsis? Arch Surg 1994; 129: 1137-42.
148. [148] Wang P, Ba ZF, Chaudry IH. Endothelium-dependent relaxation is depressed at the macro-and microcirculatory levels during sepsis. Am J Physiol 1995; 269: R988-R994.
149. [149] Zhou M, Wang P, Chaudry IH. Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis. Biochim Biophys Acta 1997; 1335: 182-90.
150. [150] Kristof AS, Noorhosseini H, Hussain SN. Attenuation of endothelium-dependent hyperpolarizing factor by bacterial lipopolysaccharides. Eur J Pharmacol 1997; 328: 69-73.
151. [151] Kessler P, Popp R, Busse R, Schini KV. Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism. Circulation 1999; 99: 1878-84.
152. [152] Corretti MC, Plotnick GD, Vogel RA. Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound. Am J Physiol 1995; 268: H1397-404.
153. [153] Bhagat K, Collier J, Vallance P. Local venous responses to endotoxin in humans. Circulation 1996; 94: 490-7.
154. [154] Hartl WH, Gunther B, Inthorn D, Heberer G. Reactive hyperemia in patients with septic conditions. Surgery 1988; 103: 440-4.
155. [155] Astiz MB, DeGent GE, Lin RY, Rackow EC. Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med 1995; 23: 265-71.
156. [156] Astiz ME, Tilly E, Rackow ED, Weil MH. Peripheral vascular tone in sepsis. Chest 1991; 99: 1072-5.
157. [157] Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23: 646-51.
158. [158] Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 1996; 24: 1179-83.
159. [159] Gardinali M, Padalino P, Vesconi S, Calcagno A, Ciappellano S, Conciato L, et al. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis Correlation with severity of disease. Arch Surg 1992; 127: 1219-24.
160. [160] Galley HF, Davies MJ, Webster NR. Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 1996; 24: 1649-53.
161. [161] Galley HF, Davies MJ, Webster NR. Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med 1996; 20; 139-43.
162. [162] Galley HF, Howdle PD, Walker BE, Webster NR. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med 1997; 23: 768-74.
163. [163] Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214: 621-6.
164. [164] Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41: 77-81.
165. [165] Endo S, Inada K, Nakae H, Arakawa N, Takakuwa T, Yamada Y, et al. Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 1996; 91: 347-56.
166. [166] Gomez-Jimenez J, Salgado A, Mourelle M, Martin MC, Segura RM, Peracaula R, et al. L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23: 253-8.
167. [167] Arnalich F, Hernanz A, Jimenez M, Lopez J, Tato E, Vazquez JJ, et al. Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock, Regul Pept 1996; 65: 115-21.
168. [168] Takakuwa T, Endo S, Inada K, Kasai T, Yamada Y, Ogawa M. Assessment of inflammatory cytokines, nitrate/nitrite, type II phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome. Res Commun Mol Pathol Pharmacol 1997; 98: 43-52.
169. [169] Doughty L, Carcillo JA, Kaplan S, Janosky J. Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis. Crit Care Med 1998; 26: 157-62.
170. [170] Spack L, Havens PL, Griffith OW. Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome. Crit Care Med 1997; 25: 1071-8.
171. [171] Duke T, South M, Stewart A. Activation of the L-arginine nitric oxide pathway in severe sepsis. Arch Dis Child 1997; 76: 203-9.
172. [172] Wong HR, Carcillo JA, Burckart G, Shah N, Janosky JE. Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. Crit Care Med 1995; 23: 835-42.
173. [173] Krafte JB, Brilli R, Szabo C, Denenberg A, Moore L, Salzman AL. Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Crit Care Med 1997; 25: 1588-93.
174. [174] Avontuur JA, Stam TC, Jongen LM, van-Amsterdam JG, Eggermont AM, Bruining HA, Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock. Intensive Care Med 1998; 24: 673-9.
175. [175] Kooy NW, Lewis SJ, Royall JA, Ye YZ, Kelly DR, Beckman JS. Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med 1997; 25: 812-9.
176. [176] Fukuyama N, Takebayashi Y, Hida M, Ishida H, Ichimori K, Nakazawa H. Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic Biol Med 1997; 22: 771-4.
177. [177] Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151: 1250-4.
178. [178] Rubin DB, Wiener Kronish JP, Murray JF, Green DR, Turner J, Luce JM, et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86: 474-80.
179. [179] Iba T, Yagi Y, Kidokoro A, Fukunaga M, Fukunaga T. Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure. Surg Today 1995; 25: 585-90.
180. [180] Moss M, Gillespie MK, Ackerson L, Moore FA, Moore EE, Parsons PE. Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med 1996; 24: 1782-6.
181. [181] Cummings CJ, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowler AA. Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 1997; 156: 431-7.
182. [182] Egerer K, Rohr U, Krausch D, Kox W. [The circulating adhesion molecules sICAM-1 and sP-selectin in patients with sepsis]. Die zirkulierenden Adhäsionsmoleküle sICAM-1 und sB-Selectin bei Patienten mit Sepsis. Anaesthesist 1997; 46: 592-8.
183. [183] Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998; 157: 776-84.
184. [184] Krafte JB, Brilli R. Increased circulating thrombomodulin in children with septic shock. Crit Care Med 1998; 26: 933-8.
185. [185] Turner GD, Ly VC, Nguyen TH, Tran TH, Nguyen HP, Bethell D, Wyllie S, et al. Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol 1998; 152: 1477-87.
186. [186] McGill SN, Ahmed NA, Christou NV. Increased plasma von Willebrand factor in the systemic inflammatory response syndrome is derived from generalized endothelial cell activation. Crit Care Med 1998; 26: 296-300.
187. [187] Endo S, Inada K, Nakae H, Takakuwa T, Kasai T, Yamada Y, et al. Blood levels of endothelin-1 and thrombomodulin in patients with disseminated intravascular coagulation and sepsis. Res Commun Mol Pathol Pharmacol 1995; 90: 277-88.
188. [188] Kurosawa S, Stearns KD, Carson CW, D'Angelo A, Della VP, Esmon CT. Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus or erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 1998; 91: 725-7.
189. [189] George F, Brouqui P, Boffa MC, Mutin M, Drancourt M, Brisson C, et al. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 1993; 82: 2109-16.
190. [190] Boldt J, Papsdorf M, Kumle B, Piper S, Hempelmann G. Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill. Crit Care Med 1998; 26: 1663-70.
191. [191] Cameron EM, Wang SY, Fink MP, Sellke FW. Mesenteric and skeletal muscle microvascular responsiveness in subacute sepsis. Shock 1998; 9: 184-92.
192. [192] Whitehurst RM, Laskey R, Goldberg RN, Herbert D, Van-Breemen C. Influence of group B streptococci on piglet pulmonary artery response to bradykinin. J Appl Physiol 1999; 86; 61-5.
193. [193] Hoque AM, Papapetropoulos A, Venema RC, Catravas JD, Fuchs LC. Effects of antisense oligonucleotide to iNOS on hemodynamic and vascular changes induced by LPS. Am J Physiol 1998; 275: H1078-H1083.
194. [194] Wang P, Wood TJ, Ba ZF, Chaudry IH. Pentoxifylline maintains vascular endothelial cell function during hyperdynamic and hypodynamic sepsis. Surgery 1996; 120: 367-73.
195. [195] Morrison AM, Wang P, Chaudry IH. A novel nonanticoagulant heparin prevents vascular endothelial cell dysfunction during hyperdynamic sepsis. Shock 1996; 6: 46-51.
196. [196] McKenna R, Laskey RE, Wang Y, Jaeschke H, Mathews WR. Effect of endotoxin-enhanced hepatic reperfusion injury on endonthelium-dependent relaxation in rat aorta. Shock 1996; 6: 106-11.
197. [197] Siegfried MR, Ma XL, Lefer AM. Splanchnic vascular endothelial dysfunction in rat endotoxemia: role of superoxide radicals. Eur J Pharmacol 1992; 212: 171-6.
198. [198] Szabo C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997; 100: 723-35.
199. [199] Vallet B, Leclerc J. Endothelial cell dysfunction in septic shock. In: Vincent JL, ed. Yearbook of intensive Care and Emergency Medicine. Berlin: Springer, 1998: 133-42.